Literature DB >> 10485156

Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease.

S O Ulualp1, B M Sterman, R J Toohill.   

Abstract

We studied the effect of antileukotriene therapy for the relief of sinus symptoms in patients with aspirin triad disease (ATD). We reviewed the charts of 18 ATD patients who had received antileukotriene therapy. All patients had undergone previous sinus surgery. We then designed a questionnaire to determine the level of each patient's symptoms of chronic rhinosinusitis before and after antileukotriene therapy. Responses were converted to symptom scores. For each patient, the role of therapy in the relief of sinus symptoms was evaluated in three ways: by total symptom scores, by self-reports of overall benefit, and by findings on endoscopic nasal examination. Fifteen of the 18 patients completed the questionnaire. Symptom scores for both major and minor symptoms indicated that nine patients had improved following antileukotriene therapy; three other patients reported some overall benefit from therapy, despite no improvement in their symptom scores. Endoscopic nasal examination findings were consistent with the reports of overall benefit. We conclude that antileukotriene therapy is an effective treatment for most patients whose symptoms of chronic rhinosinusitis persist following sinus surgery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485156

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  14 in total

Review 1.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 2.  Leukotriene antagonists in nasal polyposis: a meta-analysis and systematic review.

Authors:  Jennifer L Wentzel; Zachary M Soler; Kristen DeYoung; Shaun A Nguyen; Shivangi Lohia; Rodney J Schlosser
Journal:  Am J Rhinol Allergy       Date:  2013 Nov-Dec       Impact factor: 2.467

Review 3.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

Review 4.  The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.

Authors:  Stephen M Parnes
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

5.  Canadian guidelines for chronic rhinosinusitis: Clinical summary.

Authors:  Alan Kaplan
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

6.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

Review 7.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 8.  Antileukotrienes in upper airway inflammatory diseases.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Kagan Ipci; Ethem Şahin
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

9.  Treatment of congestion in upper respiratory diseases.

Authors:  Eli O Meltzer; Fernan Caballero; Leonard M Fromer; John H Krouse; Glenis Scadding
Journal:  Int J Gen Med       Date:  2010-04-08

Review 10.  Comparison of medical and surgical treatment of nasal polyposis.

Authors:  Glenis K Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.